Prior studies have suggested that oral contraceptives (OCs) may be associated with an increased fracture risk. However, the previous studies have only performed a limited adjustment for other potential risk factors.
Subjects and methodsAll women with a fracture (n=64,548) in the year 2000 in Denmark served as cases. For each case, three age-matched controls were randomly drawn from the general population (n=193,641). Exposure was use of OCs between January 1, 1996, and December 31, 2000. Adjustments were made for use of other drugs, pregnancy, prior fracture, other diseases and social variables.
Results
In the unadjusted analysis, use of OCs in low dose was associated with a small increase in overall fracture risk. However, upon adjustment, no increase in fracture risk could be demonstrated in any age or dose group.
Conclusion
Oral contraceptives are not associated with an increase or a decrease in fracture risk. Any change in fracture risk may be due to confounders.
oral contraceptive use fracture risk population study, oral contraceptives bone mineral density fracture risk, Vestergaard Rejnmark Mosekilde OC fracture Denmark, combined oral contraceptives skeletal effects case control, oral contraceptive dose fracture risk age groups, hormonal contraception bone health fracture confounders, low dose oral contraceptives fracture risk adjusted analysis, estrogen progestin contraceptive bone fracture population study, oral contraceptive use young women bone health fracture, Danish population case control study fracture oral contraceptives
PMID 16730486 16730486 DOI 10.1016/j.contraception.2006.01.006 10.1016/j.contraception.2006.01.006
Cite this article
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2006). Oral contraceptive use and risk of fractures. *Contraception*, *73*(6), 571-576. https://doi.org/10.1016/j.contraception.2006.01.006
Vestergaard P, Rejnmark L, Mosekilde L. Oral contraceptive use and risk of fractures. Contraception. 2006;73(6):571-576. doi:10.1016/j.contraception.2006.01.006
Vestergaard, P., et al. "Oral contraceptive use and risk of fractures." *Contraception*, vol. 73, no. 6, 2006, pp. 571-576.
Background: Epidemiological studies indicate a protective effect of postmenopausal oestrogen therapy on the risk of osteoporotic fractures. Whether premenopausal oestrogen exposure in the form of oral...
Contraception/Comparison > Health Outcomes > Bone EffectsBone Health > Fracture Risk > Oral Contraceptive AssociationResearch Methodology > Case-Control Studies > Population-Based
Objective: To examine trends in national reporting of broken intrauterine devices (IUDs).
Study Design: We enumerated IUD device "breakage" reports in the Food and Drug Administration Adverse Event R...
Objective: To evaluate overall and subgroup efficacy of an estetrol (E4) 15 mg drospirenone (DRSP) 3 mg oral contraceptive in a 24/4-day regimen.
Study Design: We pooled efficacy outcomes from 2 pivo...
Objective: The Natural Cycles app employs daily basal body temperature to define the fertile window via a proprietary algorithm and is clinically established effective in preventing pregnancy. We soug...